Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 8NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Urothelial Cancer 1Pancreatic Adenocarcinoma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 6Cisplatin 3Capecitabine 3Platinum 21,2-diaminocyclohexaneplatinum II citrate 2spartalizumab 1pembrolizumab 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Ondansetron 1Lymph Node Excision 1Dexamethasone 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gallbladder Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

SWOG Cancer Research Network

Phase 3 Completed
452 enrolled 17 charts
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡